PCM
PFE icon

Penserra Capital Management’s Pfizer PFE Stock Holding History

Penserra Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
9,522
+2,211
+30% +$57.8K ﹤0.01% 682
2026
Q1 		$204K Buy
7,311
+1,524
+26% +$40.6K ﹤0.01% 668
2025
Q4 		$143K Sell
5,787
-454
-7% -$11.4K ﹤0.01% 702
2025
Q3 		$158K Buy
6,241
+220
+4% +$5.43K ﹤0.01% 727
2025
Q2 		$145K Sell
6,021
-1,606
-21% -$37.5K ﹤0.01% 684
2025
Q1 		$192K Sell
7,627
-15,793
-67% -$413K ﹤0.01% 745
2024
Q4 		$620K Buy
23,420
+15,006
+178% +$407K 0.01% 520
2024
Q3 		$243K Buy
8,414
+2,772
+49% +$80.9K 0.01% 680
2024
Q2 		$158K Buy
5,642
+5,183
+1,129% +$143K ﹤0.01% 766
2024
Q1 		$12K Sell
459
-25,666
-98% -$712K ﹤0.01% 924
2023
Q4 		$751K Sell
26,125
-5,486
-17% -$166K 0.01% 430
2023
Q3 		$1.05M Sell
31,611
-4,951
-14% -$175K 0.02% 351
2023
Q2 		$1.34M Buy
36,562
+35,044
+2,309% +$1.36M 0.03% 340
2023
Q1 		$61K Sell
1,518
-11,782
-89% -$509K ﹤0.01% 833
2022
Q4 		$680K Buy
+13,300
New +$638K 0.01% 471
2022
Q2 		– Sell
-17,916
Closed -$926K – 1478
2022
Q1 		$926K Buy
17,916
+11,476
+178% +$595K 0.02% 414
2021
Q4 		$380K Buy
+6,440
New +$319K 0.01% 565
2020
Q4 		– Sell
-2,353
Closed -$81K – 1106
2020
Q3 		$81K Sell
2,353
-223
-9% -$7.82K ﹤0.01% 532
2020
Q2 		$79K Sell
2,576
-428
-14% -$14.5K ﹤0.01% 625
2020
Q1 		$106K Buy
3,004
+318
+12% +$10.8K 0.01% 556
2019
Q4 		$95K Buy
2,686
+518
+24% +$18.5K 0.01% 615
2019
Q3 		$73K Sell
2,168
-28,332
-93% -$1.03M 0.01% 612
2019
Q2 		$1.25M Buy
30,500
+3,025
+11% +$120K 0.1% 195
2019
Q1 		$1.06M Sell
27,475
-6,032
-18% -$242K 0.08% 213
2018
Q4 		$1.39M Sell
33,507
-9,449
-22% -$392K 0.13% 159
2018
Q3 		$1.8M Buy
+42,956
New +$1.65M 0.11% 130

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Penserra Capital Management's PFE Position: Q2 2026 in Review

Penserra Capital Management increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $57.8K and bringing the position to 9,522 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Penserra Capital Management first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $1.8M in Q3 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Penserra Capital Management held 9,522 shares of Pfizer worth $228K as of Q2 2026.
  • Penserra Capital Management bought 2,211 Pfizer shares in Q2 2026, an estimated $57.8K.
  • Pfizer made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #682 holding.
  • Penserra Capital Management first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
  • Penserra Capital Management's Pfizer position peaked at $1.8M in Q3 2018.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.